Cytek Biosciences, Inc. - stock earnings
CTKB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -6.5 million USD | 48.0 million USD |
| 2023Q2 | -4.4 million USD | 49.7 million USD |
| 2023Q1 | -6.8 million USD | 37.1 million USD |
| 2022Q4 | 3.5 million USD | 48.3 million USD |
| 2022Q3 | 1.7 million USD | 40.5 million USD |
| 2022Q2 | -702000 USD | 40.2 million USD |
| 2022Q1 | -2.2 million USD | 35.1 million USD |
| 2021Q4 | 225000 USD | 38.9 million USD |
| 2021Q3 | 1.6 million USD | 34.4 million USD |
| 2021Q2 | 2.7 million USD | 30.4 million USD |
| 2021Q1 | 102000 USD | 24.3 million USD |
| 2020Q4 | 5.6 million USD | 30.6 million USD |
| 2020Q3 | 6.5 million USD | 25.1 million USD |
| 2020Q2 | 8.1 million USD | 19.1 million USD |
| 2020Q1 | -839000 USD | 18.0 million USD |
CTKB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -14.1 million USD | 183.1 million USD |
| 2022 | 2.6 million USD | 164.0 million USD |
| 2021 | 4.4 million USD | 128.0 million USD |
| 2020 | 19.4 million USD | 92.8 million USD |
| 2019 | -16.8 million USD | 57.9 million USD |
CTKB
Price: $6.22
52 week price:
Earnings Per Share: -0.09 USD
P/E Ratio: -76.75
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 1.0 million
Market Capitalization: 855.6 million